An emerging class of orexin-based drugs are on the cusp of disrupting care for sleep disorders — and potentially much more.
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its fourth quarter and full year 2024 ...
Fanuc robots 'ease pain' for Takeda Pharmaceutical February 7, 2025 by Mark Allinson A collaborative robotic solution from Fanuc ...
New Delhi: Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...
Report with market evolution powered by AI - The global antibiotics market size is estimated to grow by USD 18.22 billion ...
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...
Discover the top 3 undervalued Pharmaceuticals stocks for Wednesday, February 05 based on AAII’s Stock Grades.
Industry giants like Takeda Pharmaceuticals, Pfizer, Novartis, and Bayer are revolutionizing treatment landscapes, paving the way for enhanced patien ...
No, Bernie Sanders and Elizabeth Warren aren’t top recipients of pharmaceutical industry donations
A quirk in the website OpenSecrets has given RFK Jr. a chance to misleadingly portray Sen. Bernie Sanders as receiving big ...
Japan’s top drugmaker, Takeda Pharmaceutical, has completed a purchase of a €75m medicines factory in Russia, as it begins to fulfil its aim of taking over the Russian market. Last year ...
A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback